« Return to News | CROs/Service Providers

Medpace Acquires European CRO, Has Big Plans for Growth

Thursday, January 21, 2010 06:04 PM

Cincinnati-based contract research organization (CRO) Medpace acquired European CRO Medical Consulting Dr. Schlichtiger for an undisclosed sum.

Based in Munich, Germany, Medical Consulting provides drug development services with a focus on regulatory consulting and pharmacovigilance. The company was founded in 1989 by Ursula Schlichtiger, M.D., now the company’s general manager.

Schlichtiger will join the Medpace team as managing director and senior director of medical and regulatory affairs.

Medpace plans to complete the integration of Medical Consulting later this year.

According to Medpace, the acquisition will strengthen the CRO’s European presence by providing centralized European hubs for regulatory submissions and approvals as well as drug safety management and reporting.

Medpace’s European headquarters is based in The Netherlands with regional offices scattered through Europe. The CRO also has Asian headquarters in Singapore and regional offices in Asia, Australia, South Africa and the Americas.

U.S. investigative sites rated Medpace the top CRO to work with in the 2009 CenterWatch Site Survey. The company has 1000 employees worldwide but plans to add another 760 by 2014. To accommodate this growth, Medpace began construction earlier this month on a new 132,000-square-foot corporate headquarters  in Cincinnati.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.